Effect of cost on early removal of contraceptive implants: a prospective cohort study.


Journal

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
ISSN: 1473-0782
Titre abrégé: Eur J Contracept Reprod Health Care
Pays: England
ID NLM: 9712127

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 8 2 2019
medline: 26 7 2019
entrez: 8 2 2019
Statut: ppublish

Résumé

To evaluate the effect of the cost of subdermal etonogestrel implant (SEI) on the continuation rate one year after insertion, and to assess the reasons given by users to remove the implant before the expiration date. Prospective cohort study conducted among 265 women who chose the SEI as a contraceptive method in a sexual and reproductive health center in the eastern region of Spain, between October/2012 and October/2017. The sample was divided into two cohorts depending on the cost of the implant for the user (free-of-charge or requiring partial payment). Kaplan-Meier survival curves were used to compare the cumulative removal rates of free implants with partially paid implants within the first year of insertion. Cox proportional hazards models were used to control for confounders. After adjusting for confounders, no significant associations were found between the cost of the implant and its removal within a year of insertion. No significant associations were found in the reasons given for implant removal and for the duration of implant use. Cost was not associated with SEI continuation rates within the first year of use. No other significant variables were found to explain implant removal within one year of use.

Identifiants

pubmed: 30730214
doi: 10.1080/13625187.2018.1564817
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Pagination

24-29

Auteurs

Manuel Lozano (M)

a Department of Preventive Medicine and Public Health, Food Science, Toxicology and Legal Medicine , University of Valencia , Valencia , Spain.
b Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (FISABIO) , Valencia , Spain.

María Antonia Obiol (MA)

c Centre for Sexual and Reproductive Health Fuente de San Luis, University Hospital Dr Peset , Valencia , Spain.

Juanjo Peiró (J)

d Department of Statistics and Operations Research , University of Valencia , Valencia , Spain.

José María Ramada (JM)

e Hospital del Mar Institute of Medical Research (IMIM) , Barcelona , Spain.
f CIBER Epidemiology and Public Health (CIBERESP) , Instituto de Salud Carlos III (ISCIII) , Madrid , Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH